-
EP2731677
European procedure
Extract from the Register of European Patents
EP About this file: EP2731677
| EP2731677 - ANTIBODIES THAT BIND TO OX40 AND THEIR USES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.02.2019 Database last updated on 16.11.2024 | |
| Former | The patent has been granted Status updated on 16.03.2018 | ||
| Former | Grant of patent is intended Status updated on 13.12.2017 | ||
| Former | Examination is in progress Status updated on 20.02.2017 | Most recent event Tooltip | 22.02.2019 | No opposition filed within time limit | published on 27.03.2019 [2019/13] | Applicant(s) | For all designated states Glenmark Pharmaceuticals S.A. Chemin de la Combeta, 5 2300 La Chaux-de-Fonds / CH | [2018/16] |
| Former [2014/21] | For all designated states Glenmark Pharmaceuticals S.A. Chemin de la Combeta, 5 2300 La Chaux-de-Fonds / CH | Inventor(s) | 01 /
ATTINGER, Antoine Chemin de la Combeta 5 2300 La Chaux-de-Fonds / CH | 02 /
BLEIN, Stanislas Chemin de la Combeta 5 2300 La Chaux-de-Fonds / CH | 03 /
BACK, Jonathan Albert Chemin de la Combeta 5 2300 La Chaux-de-Fonds / CH | 04 /
LISSILAA, Rami Chemin de la Combeta 5 2300 La Chaux-de-Fonds / CH | 05 /
HOU, Samuel Chemin de la Combeta 5 2300 La Chaux-de-Fonds / CH | [2018/16] |
| Former [2014/21] | 01 /
ATTINGER, Antoine Chemin de la Combeta 5 CH-2300 La Chaux-de-Fonds / CH | ||
| 02 /
BLEIN, Stanislas Chemin de la Combeta 5 CH-2300 La Chaux-de-Fonds / CH | |||
| 03 /
BACK, Jonathan Albert Chemin de la Combeta 5 CH-2300 La Chaux-de-Fonds / CH | |||
| 04 /
LISSILAA, Rami Chemin de la Combeta 5 CH-2300 La Chaux-de-Fonds / CH | |||
| 05 /
HOU, Samuel Chemin de la Combeta 5 CH-2300 La Chaux-de-Fonds / CH | Representative(s) | Thomas, Dean, et al Glenmark Pharmaceuticals S.A. Chemin de la Combeta 5 2300 La Chaux de Fonds / CH | [2018/16] |
| Former [2014/21] | Latscha Schöllhorn Partner Latscha Schöllhorn Partner AG Aeschenvorstadt 55 4051 Basel / CH | Application number, filing date | 12741386.2 | 09.07.2012 | [2018/16] | WO2012IB53502 | Priority number, date | US201161506491P | 11.07.2011 Original published format: US 201161506491 P | [2014/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013008171 | Date: | 17.01.2013 | Language: | EN | [2013/03] | Type: | A1 Application with search report | No.: | EP2731677 | Date: | 21.05.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.01.2013 takes the place of the publication of the European patent application. | [2014/21] | Type: | B1 Patent specification | No.: | EP2731677 | Date: | 18.04.2018 | Language: | EN | [2018/16] | Search report(s) | International search report - published on: | EP | 17.01.2013 | Classification | IPC: | A61P37/06, A61K39/00, C07K16/28 | [2017/50] | CPC: |
C07K16/2878 (EP,CN,KR,US);
A61K39/3955 (US);
A61K45/06 (EP,CN,KR,US);
A61P1/00 (EP,KR);
A61P1/02 (EP);
A61P1/04 (EP);
A61P1/12 (EP);
A61P1/14 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP,KR);
A61P11/06 (EP);
A61P13/12 (EP,KR);
A61P17/00 (EP,KR);
A61P17/02 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P19/00 (EP,KR);
A61P19/02 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P25/00 (EP,KR);
A61P25/02 (EP);
A61P25/28 (EP);
A61P27/00 (KR);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/16 (EP);
A61P33/00 (EP);
A61P33/14 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P41/00 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P7/04 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/14 (EP);
A61K2039/505 (EP,CN,KR,US);
C07K2317/24 (EP,CN,KR,US);
C07K2317/33 (EP,CN,KR,US);
C07K2317/34 (EP,CN,KR,US);
C07K2317/41 (EP,CN,KR,US);
C07K2317/52 (EP,CN,KR,US);
C07K2317/53 (EP,CN,KR,US);
C07K2317/73 (EP,CN,KR,US);
C07K2317/732 (EP,CN,KR,US);
C07K2317/76 (EP,CN,KR,US);
|
| Former IPC [2014/21] | A61P37/06, A61K39/395, C07K16/28 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/21] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | AN OX40 BINDENDE ANTIKÖRPER UND IHRE VERWENDUNGEN | [2014/21] | English: | ANTIBODIES THAT BIND TO OX40 AND THEIR USES | [2014/21] | French: | ANTICORPS QUI SE LIENT À L'OX40 ET LEURS UTILISATIONS | [2014/21] | Entry into regional phase | 10.02.2014 | National basic fee paid | 10.02.2014 | Designation fee(s) paid | 10.02.2014 | Examination fee paid | Examination procedure | 10.02.2014 | Examination requested [2014/21] | 18.06.2014 | Amendment by applicant (claims and/or description) | 22.07.2015 | Despatch of a communication from the examining division (Time limit: M04) | 09.11.2015 | Reply to a communication from the examining division | 26.02.2016 | Despatch of a communication from the examining division (Time limit: M04) | 30.06.2016 | Reply to a communication from the examining division | 10.10.2016 | Despatch of a communication from the examining division (Time limit: M06) | 15.05.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 20.07.2017 | Reply to a communication from the examining division | 14.12.2017 | Communication of intention to grant the patent | 07.03.2018 | Fee for grant paid | 07.03.2018 | Fee for publishing/printing paid | 07.03.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.07.2015 | Opposition(s) | 21.01.2019 | No opposition filed within time limit [2019/13] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 20.07.2017 | Request for further processing filed | 20.07.2017 | Full payment received (date of receipt of payment) Request granted | 31.07.2017 | Decision despatched | Fees paid | Renewal fee | 23.07.2014 | Renewal fee patent year 03 | 23.07.2015 | Renewal fee patent year 04 | 22.07.2016 | Renewal fee patent year 05 | 24.07.2017 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | RO | 18.04.2018 | RS | 18.04.2018 | SK | 18.04.2018 | BG | 18.07.2018 | [2019/10] |
| Former [2018/51] | RS | 18.04.2018 | |
| BG | 18.07.2018 | ||
| Former [2018/50] | BG | 18.07.2018 | Cited in | International search | [XI]WO2007062245 (KIRIN BREWERY [JP], et al); | [XI]WO2008106116 (GENENTECH INC [US], et al); | [XI]WO2010096418 (UCB PHARMA SA, et al) | by applicant | EP0183070 | WO8704462 | EP0244234 | WO8901036 | US4816567 | EP0338841 | EP0402226 | US5225539 | WO9316185 | WO9413804 | WO9429351 | US5530101 | US5571894 | US5585089 | US5587458 | US5624821 | US5641870 | US5648260 | US5677425 | US5693762 | US5869046 | US5924939 | US6121022 | US6165745 | US6180370 | US6194551 | US6277375 | WO03035835 | WO2010095031 | WO1992US09965 |